高血糖而无糖尿病和新发糖尿病均与 COVID-19 的预后不良相关。
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
机构信息
Department of Diabetes & Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, India.
Department of Diabetes & Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, India.
出版信息
Diabetes Res Clin Pract. 2020 Sep;167:108382. doi: 10.1016/j.diabres.2020.108382. Epub 2020 Aug 25.
Abstract
Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently available hints that both new-onset hyperglycemia without diabetes and new-onset diabetes in COVID-19 is associated with a poorer outcome compared with normoglycemic individuals and people with pre-existing diabetes.
摘要
在 COVID-19 患者中，经常会发现血糖升高或未升高的糖尿病患者，这是一种新出现的现象。越来越多的现有证据表明，与血糖正常者和患有糖尿病的患者相比，COVID-19 患者中出现的新发无糖尿病性高血糖和新发糖尿病与更差的预后相关。
相似文献
1
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.高血糖而无糖尿病和新发糖尿病均与 COVID-19 的预后不良相关。
Diabetes Res Clin Pract. 2020 Sep;167:108382. doi: 10.1016/j.diabres.2020.108382. Epub 2020 Aug 25.
2
Hyperglycemia is a strong predictor of poor prognosis in COVID-19.高血糖是 COVID-19 预后不良的一个强有力的预测指标。
Diabetes Res Clin Pract. 2020 Sep;167:108338. doi: 10.1016/j.diabres.2020.108338. Epub 2020 Jul 24.
3
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.新诊断的糖尿病和入院时的高血糖通过加重呼吸恶化预测 COVID-19 的严重程度。
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
4
Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.空腹血糖受损和糖尿病与 2019 冠状病毒病患者的并发症和死亡率升高相关。
Front Endocrinol (Lausanne). 2020 Jul 10;11:525. doi: 10.3389/fendo.2020.00525. eCollection 2020.
5
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?血糖控制不佳会增加糖尿病合并新冠病毒肺炎患者的病情严重程度及死亡率吗？
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):725-727. doi: 10.1016/j.dsx.2020.05.037. Epub 2020 May 27.
6
The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.韩国大邱市 2019 年冠状病毒病中度至重度感染合并糖尿病患者的临床特征和结局。
Diabetes Metab J. 2020 Aug;44(4):602-613. doi: 10.4093/dmj.2020.0146. Epub 2020 Aug 12.
7
[Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].[2020年，糖尿病和高血压作为墨西哥索诺拉州与新冠病毒致死率相关的因素]
Salud Publica Mex. 2020 Sep-Oct;62(5):456-457. doi: 10.21149/11546.
8
[The endocrine and metabolic link between COVID-19, diabetes and obesity].[新型冠状病毒肺炎、糖尿病与肥胖之间的内分泌及代谢联系]
Ugeskr Laeger. 2020 Jul 13;182(29).
9
Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.血糖水平升高预示 COVID-19 住院患者预后不良：一项回顾性队列研究。
BMJ Open Diabetes Res Care. 2020 Jun;8(1). doi: 10.1136/bmjdrc-2020-001476.
10
Commentary: COVID-19 in patients with diabetes.评论：糖尿病患者中的2019冠状病毒病
Metabolism. 2020 Jun;107:154217. doi: 10.1016/j.metabol.2020.154217. Epub 2020 Mar 24.
引用本文的文献
1
Hyperglycemia, diabetes, and de novo diabetes in patients hospitalized in intensive care units for COVID-19 in Colombia: Results from a longitudinal cohort study.哥伦比亚新冠肺炎重症监护病房住院患者的高血糖、糖尿病和新发糖尿病：一项纵向队列研究的结果
J Crit Care Med (Targu Mures). 2025 Jul 31;11(3):257-264. doi: 10.2478/jccm-2025-0026. eCollection 2025 Jul.
2
Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.肥胖对非人灵长类动物感染SARS-CoV-2的急性反应及新冠病毒感染后急性后遗症（PASC）发展的影响。
PLoS Pathog. 2025 Jul 24;21(7):e1012988. doi: 10.1371/journal.ppat.1012988. eCollection 2025 Jul.
3
The Impact of SARS-CoV-2 Infection on Glucose Homeostasis in Hospitalized Patients with Pulmonary Impairment.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对合并肺部损伤的住院患者血糖稳态的影响
Diagnostics (Basel). 2025 Feb 25;15(5):554. doi: 10.3390/diagnostics15050554.
4
Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.肥胖对非人灵长类动物感染SARS-CoV-2的急性反应及新冠病毒感染后急性后遗症（PASC）发展的影响。
bioRxiv. 2025 Feb 22:2025.02.18.638792. doi: 10.1101/2025.02.18.638792.
5
Clinical features of and severity risk factors for COVID-19 in adults during the predominance of SARS-CoV-2 XBB variants in Okinawa, Japan.日本冲绳地区在 SARS-CoV-2 XBB 变异株流行期间成年人 COVID-19 的临床特征和严重程度危险因素。
PLoS One. 2024 Oct 31;19(10):e0309808. doi: 10.1371/journal.pone.0309808. eCollection 2024.
6
Insulin Resistance in Long COVID-19 Syndrome.长新冠综合征中的胰岛素抵抗
J Pers Med. 2024 Aug 28;14(9):911. doi: 10.3390/jpm14090911.
7
Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia.沙特阿拉伯宰德地区 COVID-19 患者中新发糖尿病的患病率及其短期临床影响。
BMC Endocr Disord. 2024 Sep 20;24(1):197. doi: 10.1186/s12902-024-01724-z.
8
Effect of fasting plasma glucose level in severe fever and thrombocytopenia syndrome patients without diabetes.重症发热伴血小板减少综合征患者无糖尿病时的空腹血糖水平的影响。
PLoS Negl Trop Dis. 2024 Apr 16;18(4):e0012125. doi: 10.1371/journal.pntd.0012125. eCollection 2024 Apr.
9
Long-Term Persistence of COVID-Induced Hyperglycemia: A Cohort Study.COVID 相关高血糖的长期持续存在：一项队列研究。
Am J Trop Med Hyg. 2024 Feb 13;110(3):512-517. doi: 10.4269/ajtmh.22-0695. Print 2024 Mar 6.
10
Assessment of the Negative Factors for the Clinical Outcome in Patients with SARS-CoV-2 Infection and Type 2 Diabetes Mellitus.新型冠状病毒2型感染者合并2型糖尿病患者临床结局的负面因素评估
Diabetes Metab Syndr Obes. 2024 Jan 22;17:271-282. doi: 10.2147/DMSO.S447835. eCollection 2024.
本文引用的文献
1
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.新诊断的糖尿病和入院时的高血糖通过加重呼吸恶化预测 COVID-19 的严重程度。
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
2
Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.入院时高血糖与 COVID-19 住院患者预后严重程度相关：比萨 COVID-19 研究。
Diabetes Care. 2020 Oct;43(10):2345-2348. doi: 10.2337/dc20-1380. Epub 2020 Aug 11.
3
COVID-19 in people with diabetes: understanding the reasons for worse outcomes.COVID-19 与糖尿病：了解预后不佳的原因。
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792. doi: 10.1016/S2213-8587(20)30238-2. Epub 2020 Jul 17.
4
Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.入院时的空腹血糖是 COVID-19 患者（无既往糖尿病诊断）28 天死亡率的独立预测因子：一项多中心回顾性研究。
Diabetologia. 2020 Oct;63(10):2102-2111. doi: 10.1007/s00125-020-05209-1. Epub 2020 Jul 10.
5
Hyperglycaemia on admission to hospital and COVID-19.入院时的高血糖与新型冠状病毒肺炎
Diabetologia. 2020 Nov;63(11):2486-2487. doi: 10.1007/s00125-020-05216-2. Epub 2020 Jul 6.
6
New-Onset Diabetes in Covid-19.新冠病毒感染引发的新发糖尿病
N Engl J Med. 2020 Aug 20;383(8):789-790. doi: 10.1056/NEJMc2018688. Epub 2020 Jun 12.
7
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.新诊断的糖尿病与 COVID-19 住院患者的已知糖尿病相比，与死亡率升高相关。
Diabetes Obes Metab. 2020 Oct;22(10):1897-1906. doi: 10.1111/dom.14099. Epub 2020 Jun 30.
8
Why is hyperglycaemia worsening COVID-19 and its prognosis?为什么高血糖会加重2019冠状病毒病及其预后？
Diabetes Obes Metab. 2020 Oct;22(10):1951-1952. doi: 10.1111/dom.14098. Epub 2020 Jun 21.
9
COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes.新冠病毒疾病（COVID-19）症状掩盖了1型糖尿病的首次酮症酸中毒。
Diabetes Metab. 2021 Feb;47(1):101162. doi: 10.1016/j.diabet.2020.05.004. Epub 2020 May 21.
10
The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan.武汉某中心医院回顾性观察研究：2019 年冠状病毒病合并糖尿病与高血糖的临床特征和转归。
Diabetes Obes Metab. 2020 Aug;22(8):1443-1454. doi: 10.1111/dom.14086. Epub 2020 Jun 17.
Zotero 插件